MET

Report

Delayed Nyse - 04/16 04:10:00 pm
63.07	USD		+1.24%

04/13

METLIFE : Earns 2021 ENERGY STAR® ‘Sustained Excellence' Award

04/12

METLIFE : Barclays Adjusts MetLife's Price Target to $69 From $65, Maintains Overweight Rating

04/07

ZURICH INSURANCE : Farmers Exchanges Wrap Up $3.9 Billion Acquisition of MetLife P&C Unit

Summary

Quotes 5-day view Delayed Quote.

Delayed Nyse

04/12/2021	04/13/2021	04/14/2021	04/15/2021	04/16/2021	Date
62.66(c)	62.05(c)	62.73(c)	62.3(c)	63.07(c)	Last
2 671 386	3 406 694	4 341 407	4 553 769	4 044 511	Volume
+1.20%	-0.97%	+1.10%	-0.69%	+1.24%	Change

More quotes

Financials (USD)

Sales 2021	64 944 M - -
Net income 2021	4 754 M - -
Net Debt 2021	- - -
P/E ratio 2021	11,2x
Yield 2021	3,04%

Sales 2022	66 752 M - -
Net income 2022	5 312 M - -
Net Debt 2022	- - -
P/E ratio 2022	10,3x
Yield 2022	3,20%

Capitalization	55 779 M 55 779 M -
Capi. / Sales 2021	0,86x
Capi. / Sales 2022	0,84x
Nbr of Employees	-
Free-Float	63,7%

More Financials

Company

MetLife, Inc. (MetLife) is a financial services company. The Company is principally engaged in providing insurance, annuities, employee benefits and asset management services. The Company's segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); and MetLife Holdings. Its U.S. segment is organized into Group Benefits, and Retirement and Income Solutions. The Company's Asia segment...

Sector

Life & Health Insurance

Calendar

05/05

Earnings Release

More about the company

Notations Surperformance© of MetLife, Inc.

Trading Rating :

Investor Rating :

More Ratings

All news about METLIFE, INC.

04/13	METLIFE : Earns 2021 ENERGY STAR® ‘Sustained Excellence' Award	BU
04/12	METLIFE : Barclays Adjusts MetLife's Price Target to $69 From $65, Maintains Ov..	MT
04/07	ZURICH INSURANCE : Farmers Exchanges Wrap Up $3.9 Billion Acquisition of MetLif..	MT
04/07	METLIFE : Completes Sale of Auto & Home Business to Zurich Insurance Group Subs..	BU
04/07	METLIFE : to Hold Conference Call for First Quarter 2021 Results	BU
04/05	METLIFE : JPMorgan Adjusts MetLife's Price Target to $64 From $58, Maintains Ov..	MT
04/01	METLIFE INVESTMENT MANAGEMENT : Announces Partnership With Girls Who Invest	BU
04/01	METLIFE : Plans 'Aggressive' Share Buybacks as Pandemic Costs Ease, RBC Says	MT
04/01	METLIFE : Morgan Stanley Adjusts MetLife's Price Target to $70 from $60, Keeps ..	MT
04/01	METLIFE : Price Target From RBC Raised to $66 From $57 Amid Improving Sentiment..	MT
03/31	METLIFE : Half of Young Employees Say Pandemic Made Work-Life Balance Better; 3..	BU
03/29	METLIFE INVESTMENT MANAGEMENT : to Provide USD 161 Million / GBP 117.5 Million ..	BU
03/26	U.S. regulators inch toward pet-insurance rules as Sir Purrs A Lot ails	RE
03/26	SECTOR UPDATE : Financial Stocks Climb Premarket Friday	MT
03/26	METLIFE : Reports Increase in 2020 Total Agricultural Mortgage Loan Assets Unde..	MT

More news

News in other languages on METLIFE, INC.

04/08	Principales informations avant-Bourse
04/07	Zurich schliesst Kauf des US-Schaden- und Unfallgeschäfts von Metlife ab
03/31	USA : Yellen vuole rilanciare attività Financial Stability Oversight Council
03/03	ASSICURAZIONI : MetLife lancia in Italia nuova piattaforma di e-commerce
02/23	WALL STREET: resta in calo dopo Powell, Nasdaq perde oltre 2%

More news

Analyst Recommendations on METLIFE, INC.

04/12	METLIFE : Barclays Adjusts MetLife's Price Target to $69 From $65, Maintains Ov..	MT
04/05	METLIFE : JPMorgan Adjusts MetLife's Price Target to $64 From $58, Maintains Ov..	MT
04/01	METLIFE : Morgan Stanley Adjusts MetLife's Price Target to $70 from $60, Keeps ..	MT

More recommendations

Provided by Scoopnest.com

Analysis

U.S. regulators inch toward pet-insurance rules as Sir Purrs A Lot ails

More Must read

Chart METLIFE, INC.

Duration : Period :

MetLife, Inc. Technical Analysis Chart | MarketScreener

Full-screen chart

Technical analysis trends METLIFE, INC.

	Short Term	Mid-Term	Long Term
Trends	Bullish	Bullish	Bullish

Technical analysis

Income Statement Evolution

More Financials

Consensus

Sell

Buy

Mean consensus	OUTPERFORM
Number of Analysts	14
Average target price	64,62 $
Last Close Price	63,07 $
Spread / Highest target	11,0%
Spread / Average Target	2,45%
Spread / Lowest Target	-23,9%

Consensus

EPS Revisions

More Estimates Revisions

Managers and Directors

Name	Title
Michel A. Khalaf	President, Chief Executive Officer & Director
John D. McCallion	Chief Financial Officer & Executive Vice President
Robert Glenn Hubbard	Chairman
Jacki Goldstein	Chief Medical Officer
Bill Pappas	Executive VP & Head-Global Technology & Operations

More about the company

Sector and Competitors

	1st jan.	Capitalization (M$)

METLIFE, INC.	32.69%	55 779



AXA	21.49%	66 826
PRUDENTIAL PLC	15.26%	56 339
MANULIFE FINANCIAL CORPORATION	18.15%	41 838
PRUDENTIAL FINANCIAL, INC.	26.66%	38 628
AFLAC INCORPORATED	20.19%	36 326

More Results